PMID- 35494975 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220503 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 14 IP - 3 DP - 2022 Mar TI - Diagnosed by Reversibility: Unmasking Propofol-Related Infusion Syndrome in a Critically-Ill Elderly Male. PG - e23504 LID - 10.7759/cureus.23504 [doi] LID - e23504 AB - Propofol-related infusion syndrome (PRIS) is an uncommon complication resulting from prolonged propofol use. Common clinical presentations include metabolic acidosis, cardiac arrhythmias, and renal complications. The mortality rate is high if it is not recognized in time. There is no antidote to propofol. Initial treatment involves discontinuing ongoing propofol use and providing supportive measures. The reversal of clinical and laboratory features upon discontinuation of propofol provides a basis for retrospective diagnosis or PRIS. In severe cases, ultrafiltration may be utilized. CI - Copyright (c) 2022, Ayele et al. FAU - Ayele, Tewodros AU - Ayele T AD - Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA. FAU - Ezeh, Ebubechukwu AU - Ezeh E AD - Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA. FAU - Al-Qawasmi, Leesah AU - Al-Qawasmi L AD - Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA. FAU - Ugonabo, Onyinye S AU - Ugonabo OS AD - Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA. FAU - Saylor, John AU - Saylor J AD - Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA. FAU - Dial, Larry AU - Dial L AD - Internal Medicine, Marshall University Joan C. Edwards School of Medicine, Huntington, USA. LA - eng PT - Case Reports DEP - 20220326 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC9038587 OTO - NOTNLM OT - anesthesia OT - critically ill elderly patients OT - intensive care OT - metabolic acidosis OT - pris OT - propofol OT - propofol infusion syndrome COIS- The authors have declared that no competing interests exist. EDAT- 2022/05/03 06:00 MHDA- 2022/05/03 06:01 PMCR- 2022/03/26 CRDT- 2022/05/02 06:35 PHST- 2022/03/25 00:00 [accepted] PHST- 2022/05/02 06:35 [entrez] PHST- 2022/05/03 06:00 [pubmed] PHST- 2022/05/03 06:01 [medline] PHST- 2022/03/26 00:00 [pmc-release] AID - 10.7759/cureus.23504 [doi] PST - epublish SO - Cureus. 2022 Mar 26;14(3):e23504. doi: 10.7759/cureus.23504. eCollection 2022 Mar.